See also this year's filing and all EDGAR filings for this company.
PDF Report 0001361248_2016_Tetralogic_Pharmaceuticals_Corp.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001361248, Tetralogic Pharmaceuticals Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 21,970,714 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 41,575,516 |
| 2 | PropertyPlantAndEquipmentNet | 417,815 |
| 3 | remainder_Assets | 57,345 |
| 4 | LiabilitiesCurrent | 3,659,748 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 66,302,368 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,098,577 |
| 9 | ResearchAndDevelopmentExpense | 27,401,669 |
| 10 | remainder_Expenses | 12,875,065 |
| 11 | remainder_Revenues | 99,605 |
| 12 | remainder_NetIncome | 1,551,652 |
| 13 | remainder_ComprehensiveNetIncome | 5,387 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,021,390 |
| 1 | Liabilities | 69,962,116 |
| 2 | Expenses | 51,375,311 |
| 3 | Revenues | 99,605 |
| 4 | StockholdersEquity | -5,940,726 |
| 5 | NetIncome | -49,724,054 |
| 6 | ComprehensiveNetIncome | -49,721,360 |
| 7 | BaseVar | 93,507,730 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.936 |
| 9 | EconomicCapitalRatio | 1.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
